Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Patient demographics and surgical results

From: Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial

  ZA group (n = 27) Control group (n = 27)
Age (years), mean (SD) 60.1 (11.7) 59.4 (13.3)
Sex, female:male 15:12 14:13
BMI (kg/m2), mean (SD) 26 (4) 25 (5)
Operation time (minutes), mean (SD)a 118 (27) 103 (17)
Blood loss (mL), mean (SD) 502 (312) 387 (162)
Diagnosis (OA/AVN) 16/11 17/10
  1. BMI body mass index, SD standard deviation, ZA zoledronic acid, OA osteoarthritis, AVN avascular necrosis
  2. astatistically significant difference between the ZA and control groups (P < 0.05)